Alexza Pharmaceuticals (ALXA) Tops Q2 EPS by 4c
More News related to ALXA
- Alexza Pharmaceuticals (ALXA) Reports Large Q3 Loss
- Alexza Reports 2009 Third Quarter Financial Results and Updates AZ-004 (Staccato(R) Loxapine) NDA Status
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
- Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
More News related to Earnings
- Denison Mines (DNN) Posts Q3 Loss of $0.27, Misses Views
- RailAmerica (RA) Reports Q3 EPS of $0.08
- Western Gas Partners (WES) Posts Q3 EPS of $0.30, Beats by 3c
- Kongzhong (KONG) Posts Q3 non-GAAP EPS of $0.16, Tops by 6c
- Applied Materials (AMAT) Post Better Than Expected Profit, But To Show 1,500 Workers The Door
Alexza Pharmaceuticals (Nasdaq: ALXA) reports a Q2 loss of $0.43, 4 cents better than the analyst estimate of ($0.47). No revenues were reported for the quarter.
Related Categories
EarningsStocks Mentioned
+0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
